In mammary ductal in situ breast cancer of comedo-type, ductal carcinoma in situ (DCIS) cells surrounding the central necrosis exhibited high HIF-1α protein levels, down-regulated ER-α, and increased expression of the epithelial breast stem cell marker CK-19 [41]. The gene discussed is HIF1A; the disease is ductal breast carcinoma in situ.